Ülke: Birleşik Krallık
Dil: İngilizce
Kaynak: MHRA (Medicines & Healthcare Products Regulatory Agency)
Ivermectin
Galderma (UK) Ltd
D11AX22
Ivermectin
10mg/1gram
Cutaneous cream
Cutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 13060300; GTIN: 05020465201038 05020465202264
OBJECT 1 SOOLANTRA 10MG/G CREAM Summary of Product Characteristics Updated 13-Apr-2018 | Galderma (U.K) Ltd 1. Name of the medicinal product Soolantra 10 mg/g cream 2. Qualitative and quantitative composition One gram of cream contains 10 mg of ivermectin. Excipient(s) with known effect: One gram of cream contains 35 mg of cetyl alcohol, 25 mg of stearyl alcohol, 2 mg of methyl parahydroxybenzoate (E218), 1 mg of propyl parahydroxybenzoate (E216) and 20 mg of propylene glycol. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Cream. White to pale yellow hydrophilic cream. 4. Clinical particulars 4.1 Therapeutic indications Soolantra is indicated for the topical treatment of inflammatory lesions of rosacea (papulopustular) in adult patients. 4.2 Posology and method of administration Posology One application a day for up to 4 months. Soolantra should be applied daily over the treatment course. The treatment course may be repeated. In case of no improvement after 3 months, the treatment should be discontinued. _Special population_ _Renal impairment_ No dosage adjustment is necessary. _Hepatic impairment_ Caution should be exercised in patients with severe hepatic impairment. _Elderly patients_ No dosage adjustment is necessary in the geriatric population (see also section 4.8). _Paediatric population_ The safety and efficacy of Soolantra in children and adolescents aged less than 18 years have not been established. No data are available. Method of administration Cutaneous use only. Cutaneous application of a pea-size amount of medicinal product to each of the five areas of the face: forehead, chin, nose, and each cheek. The medicinal product should be spread as a thin layer across the entire face, avoiding the eyes, lips and mucosa. Soolantra should be applied only to the face. Hands should be washed after applying the medicinal product. Cosmetics may be applied after the medicinal product has dried. 4.3 Contraindications Hypersensitivity to the active substance or to any of the excipients lis Belgenin tamamını okuyun